"Designing Growth Strategies is in our DNA"

Ozempic Market Size, Share & Industry Analysis, By Indication (Type 2 Diabetes Mellitus, T2DM with Established CVD / CV Risk Reduction Use, T2DM with CKD / Renal Risk Reduction Use, and Others), By Dose (0.25 mg / Initiation Use, 0.5 mg, 1 mg, and 2 mg), By Type (Branded and Generic), By Form (Prefilled Multi-dose Pens, Prefilled Single-dose Pens, and Others), By Age Group (Pediatrics and Adults), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2026-2034

Last Updated: April 02, 2026 | Format: PDF | Report ID: FBI115840

 


To get information on various segments, share your queries with us

ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year  2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 5.74% from 2026 to 2034
Unit Value (USD Billion)
Segmentation By Indication, Dose, Type, Form, Age Group, Distribution Channel, and Region
By Indication
  • Type 2 Diabetes Mellitus
  • T2DM with Established CVD / CV Risk Reduction Use
  • T2DM with CKD / Renal Risk Reduction Use 
  • Others
By Dose
  • 0.25 mg / Initiation Use
  • 0.5 mg
  • 1 mg
  • 2 mg
By Type
  • Branded
  • Generic
By Form
  • Prefilled Multi-dose Pens
  • Prefilled Single-dose Pens
  • Others
By  Age Group
  • Pediatrics
  • Adults
By  Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
By Region 
  • North America (By Indication, Dose, Type, Form, Age Group, Distribution Channel, and Country)
    • U.S. 
    • Canada
  • Europe (By Indication, Dose, Type, Form, Age Group, Distribution Channel, and Country/Sub-region)
    • Germany 
    • U.K.
    • France 
    • Spain 
    • Italy 
    • Scandinavia 
    • Rest of Europe
  • Asia Pacific (By Indication, Dose, Type, Form, Age Group, Distribution Channel, and Country/Sub-region)
    • China 
    • Japan 
    • India 
    • Australia 
    • Southeast Asia 
    • Rest of Asia Pacific 
  • Latin America (By Indication, Dose, Type, Form, Age Group, Distribution Channel, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Indication, Dose, Type, Form, Age Group, Distribution Channel, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

 

  • 2021-2034
  • 2025
  • 2021-2024
  • 204
Download Free Sample

    man icon
    Mail icon

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann